Today’s AI Top Pick: IDN
7/28/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live IDN price forecast →
IDN (Intellicheck) is the cleanest setup on this list because it satisfies the rulebook almost perfectly: deeply oversold with room to run, strong multi-timeframe forecast alignment on the shorter frames, and a real business underneath. Price is $3.63, sitting at 0% of the 1d 21-bar range and 4.11% on the 4h — this is textbook 'not chasing.' RSI is 29.69 (oversold), the 21-bar drawdown is -15% daily and -12% on the 1h, yet Kronos gives bullish_prob = 1 with near-term_bullish 0.8. That's a mean-reversion setup with real conviction attached. Multi-timeframe forecasts are aligned to the upside on the actionable horizons: 1h fc_short +37.61% / mid +70.38% / long +157.7%; 4h +43.19 / +51.91 / +53.04; 1d +0.01 / +47.69 / +44.42. The 1wk is the only soft frame (short -0.19, mid -2.32, long +5.42) — but that's flat, not deteriorating, and the -22.77% weekly move that got us here is precisely what's creating the setup. The magnitude of the mid/long-horizon forecasts (+44% to +157%) is materially larger than any other name that isn't already extended. Fundamentals support the tape rather than fight it. IDN is a real, profitable microcap: ROE 11.38, profitMargin 9.56, grossMargin 90.68 (SaaS-quality), operMargin 8.48, debtEq 0, salesYoY +15.26, epsNextY +25.93, recom 1.67, and analyst target upside 106.6%. The fwdPe of 21.35 is reasonable for a growth-plus-profitable identity-verification play. Fundamental_score is 5.75 — same as TASK but without TASK's 2.86 recom flag. News is quiet (one AI-fraud piece from July 7), so no landmine risk and no crowded catalyst — the setup is purely mechanical. Why today over waiting: waiting for confirmation on a name that's already at 0% of range means paying up after the 1h/4h reversal is visible. The forecast engine is pricing the reversal now, RSI is at 29.69, and the -15% drawdown gives a defined risk. Chasing HURN (99% of 4h range, earnings ahead) or TASK (94% of 4h range) means buying tops with equal-or-worse forecast asymmetry. IDN gives you the same bullish_prob at a much better cost basis.

- Weekly tape is soft: 1wk recent_21bar -22.77% and dd_from_high -57.24% means the broader trend is still down — this is a counter-trend bet
- Microcap ($73.5M) with 6.36% short float — can move violently in either direction on low volume
- Only one recent headline (from July 7) means no near-term catalyst to force the reversal — this is a pure signal/fundamentals trade that may need patience
- 1d fc_short is essentially 0% (0.01%) — the immediate next few sessions may chop before the mid-horizon +47% forecast plays out
- PE of 33.46 leaves no margin for error if the growth miss expectations at next print
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | IDN | BUY NOW | 8.4 | Oversold (RSI 29.69) at 0% of daily range with 1h/4h/1d forecasts of +44%–+157% and clean fundamentals — best risk/reward on the list. |
| 2 | TASK | BUY PULLBACK | 8.1 | Momentum + value combo (PE 5.11, 4h fc mid +92%) with Wedbush tailwind, but at 94% of 4h range — better entry on a pullback to $5.30. |
| 3 | HURN | BUY PULLBACK | 7.7 | Highest fundamental_score (7.0) with recom 1 and 58% analyst upside, but 99% of 4h range and earnings looming — wait for post-print pullback. |
| 4 | MORN | BUY PULLBACK | 7.3 | Strong 1d/1wk long forecasts (+17.4% / +30.1%) and quality fundamentals, but 'fully priced' headline and position at 89% of 1d range argues for patience. |
| 5 | IDR | BUY NOW | 6.8 | Rare-earth/critical-minerals with real profitability (ROE 27.48, profitMargin 43.33), oversold at 18% of 1d range, 1h/4h fc +34–50%. |
| 6 | CSV | BUY PULLBACK | 6.4 | Zacks upgrade to Buy + fundamental_score 6.25, but at 100% of both 4h and 1d ranges — pure chase. |
| 7 | BCDA | WAIT | 5.6 | Deep oversold with 1wk fc +264%, but the magnitude looks like an outlier and fundamentals are dire (ROE -950). |
| 8 | CCB | WAIT | 5.3 | Strong 1d mid/long fc (+33%/+27%) but 1wk fc is -37% long and CFO transition is a red flag. |
| 9 | QNTM | WAIT | 5.1 | Oversold biotech with 1d fc +85%/+103%, but ROE -984 and 1wk fc_short -43% is a mixed signal. |
| 10 | TGEN | WAIT | 5.0 | Real orders news ($3.3M) and oversold, but 1wk fc turns negative -47% long. |
| 11 | MBRX | AVOID | 4.8 | MIRACLE trial fell short of significance June 30, 1wk fc -57% flat across horizons — thesis broken. |
| 12 | DRMA | WAIT | 4.7 | 1wk fc of +2807%/+1007%/+4420% is a clear outlier — do not trust. |
| 13 | AKTX | WAIT | 4.5 | Maxim upgrade to Buy $30 target is nice, but 1wk fc -100% across all horizons is a red flag on the model itself. |
| 14 | LTRN | WAIT | 4.4 | Patent allowance and platform launch are positives; 1d fc +27%/+17%, but epsNextY is -33.77%. |
| 15 | PRSO | AVOID | 4.2 | $25M Roth stock purchase agreement June 30 = dilution overhang; salesYoY -40.57%. |
| 16 | INTZ | WAIT | 4.2 | Strong 1d fc +69%/+88%, but profitMargin -169% and salesYoY -3.21%. |
| 17 | ATRA | AVOID | 4.1 | 1wk fc -80% across all horizons; salesYoY -88.41%. |
| 18 | GLMD | WAIT | 4.0 | Formulation news but $4.36M market cap and 1h fc heavy vs 1wk fc +321% mid is suspicious. |
| 19 | TNXP | WAIT | 4.0 | Medicare coverage win is real, but 1wk fc of +26,564% is a garbage-out model signal. |
| 20 | XTLB | WAIT | 3.9 | Only bullish tape signal is 1wk fc +104%; no fundamentals visible. |
| 21 | LUCY | WAIT | 3.8 | Claude AI integration is a positive narrative, but warrant exercise dilution and recom 3.0. |
| 22 | DARE | WAIT | 3.7 | Very oversold (RSI 26.83), 1h fc +96%, but profitMargin -1038% and debtEq 9.84. |
| 23 | RGNT | WAIT | 3.6 | Japan/EU regulatory wins are real positives, but bullish_prob is null and perfYtd -69.44%. |
| 24 | NXTC | AVOID | 3.5 | NXTC merging with Avere in all-stock deal — thesis fundamentally changed, existing signal invalid. |
| 25 | YCBD | WAIT | 3.4 | Deep drawdown -35% daily, small distribution win in SC, but $5.46M market cap and RSI 28.22. |
| 26 | WW | WAIT | 3.3 | Only 1d data available; PE 0.13 is likely an artifact — insufficient tape signal. |
| 27 | IPWR | AVOID | 3.0 | $75M shelf filing July 10 = dilution overhang; PS ratio 2151.3 is not a typo. |
| 28 | USBC | AVOID | 2.8 | 1d fc_short -68% and 1wk fc +1193% is model contradiction; targetUpside 12,400% is unreliable. |
| 29 | CNCK | WAIT | 2.7 | 1h/4h fc negative -29%/-17% despite 1wk +266% — near-term tape says wait. |
| 30 | CRE | AVOID | 2.5 | perfYear -95%, targetUpsidePct null, incomplete tape data. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord